nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Consciousness abnormal—Vincristine—sarcoma	0.0562	0.0562	CcSEcCtD
Propericiazine—Abnormal pigmentation—Epirubicin—sarcoma	0.047	0.047	CcSEcCtD
Propericiazine—Prolonged menses—Vincristine—sarcoma	0.0465	0.0465	CcSEcCtD
Propericiazine—Abnormal pigmentation—Doxorubicin—sarcoma	0.0435	0.0435	CcSEcCtD
Propericiazine—Pigmentation disorder—Thiotepa—sarcoma	0.033	0.033	CcSEcCtD
Propericiazine—Pigmentation disorder—Etoposide—sarcoma	0.0237	0.0237	CcSEcCtD
Propericiazine—Ileus paralytic—Vincristine—sarcoma	0.0226	0.0226	CcSEcCtD
Propericiazine—Altered state of consciousness—Vincristine—sarcoma	0.0211	0.0211	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—sarcoma	0.0195	0.0195	CcSEcCtD
Propericiazine—Sudden death—Mitoxantrone—sarcoma	0.0186	0.0186	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—sarcoma	0.0181	0.0181	CcSEcCtD
Propericiazine—Venous thromboembolism—Epirubicin—sarcoma	0.0151	0.0151	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—sarcoma	0.0139	0.0139	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—sarcoma	0.0133	0.0133	CcSEcCtD
Propericiazine—Menorrhagia—Vincristine—sarcoma	0.0132	0.0132	CcSEcCtD
Propericiazine—Menorrhagia—Mitoxantrone—sarcoma	0.0128	0.0128	CcSEcCtD
Propericiazine—Amenorrhoea—Thiotepa—sarcoma	0.0125	0.0125	CcSEcCtD
Propericiazine—Pigmentation disorder—Doxorubicin—sarcoma	0.0123	0.0123	CcSEcCtD
Propericiazine—Amenorrhoea—Mitoxantrone—sarcoma	0.0108	0.0108	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—sarcoma	0.00878	0.00878	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—sarcoma	0.00812	0.00812	CcSEcCtD
Propericiazine—Weight increased—Thiotepa—sarcoma	0.00628	0.00628	CcSEcCtD
Propericiazine—Hypokalaemia—Mitoxantrone—sarcoma	0.00628	0.00628	CcSEcCtD
Propericiazine—Hyperglycaemia—Thiotepa—sarcoma	0.00623	0.00623	CcSEcCtD
Propericiazine—Pneumonia—Thiotepa—sarcoma	0.00619	0.00619	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—sarcoma	0.00614	0.00614	CcSEcCtD
Propericiazine—Jaundice—Thiotepa—sarcoma	0.006	0.006	CcSEcCtD
Propericiazine—Sweating increased—Mitoxantrone—sarcoma	0.00581	0.00581	CcSEcCtD
Propericiazine—Agranulocytosis—Thiotepa—sarcoma	0.00574	0.00574	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—sarcoma	0.0057	0.0057	CcSEcCtD
Propericiazine—Erectile dysfunction—Vincristine—sarcoma	0.00564	0.00564	CcSEcCtD
Propericiazine—Photosensitivity reaction—Vincristine—sarcoma	0.00559	0.00559	CcSEcCtD
Propericiazine—Erectile dysfunction—Mitoxantrone—sarcoma	0.00549	0.00549	CcSEcCtD
Propericiazine—Pneumonia—Vincristine—sarcoma	0.00549	0.00549	CcSEcCtD
Propericiazine—Weight increased—Mitoxantrone—sarcoma	0.00542	0.00542	CcSEcCtD
Propericiazine—Hyperglycaemia—Mitoxantrone—sarcoma	0.00538	0.00538	CcSEcCtD
Propericiazine—Pneumonia—Mitoxantrone—sarcoma	0.00534	0.00534	CcSEcCtD
Propericiazine—Drowsiness—Mitoxantrone—sarcoma	0.00531	0.00531	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—sarcoma	0.00526	0.00526	CcSEcCtD
Propericiazine—Jaundice—Mitoxantrone—sarcoma	0.00518	0.00518	CcSEcCtD
Propericiazine—Cardiac disorder—Thiotepa—sarcoma	0.00513	0.00513	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—sarcoma	0.00504	0.00504	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—sarcoma	0.00504	0.00504	CcSEcCtD
Propericiazine—Agranulocytosis—Mitoxantrone—sarcoma	0.00496	0.00496	CcSEcCtD
Propericiazine—Arrhythmia—Thiotepa—sarcoma	0.00493	0.00493	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—sarcoma	0.00487	0.00487	CcSEcCtD
Propericiazine—Sweating increased—Etoposide—sarcoma	0.00483	0.00483	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—sarcoma	0.00471	0.00471	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—sarcoma	0.00466	0.00466	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—sarcoma	0.00466	0.00466	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—sarcoma	0.00457	0.00457	CcSEcCtD
Propericiazine—Cardiac disorder—Vincristine—sarcoma	0.00455	0.00455	CcSEcCtD
Propericiazine—Vision blurred—Thiotepa—sarcoma	0.00453	0.00453	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—sarcoma	0.00445	0.00445	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—sarcoma	0.00443	0.00443	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—sarcoma	0.00443	0.00443	CcSEcCtD
Propericiazine—Agitation—Thiotepa—sarcoma	0.00442	0.00442	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—sarcoma	0.00436	0.00436	CcSEcCtD
Propericiazine—Jaundice—Etoposide—sarcoma	0.00431	0.00431	CcSEcCtD
Propericiazine—Arrhythmia—Mitoxantrone—sarcoma	0.00426	0.00426	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—sarcoma	0.00423	0.00423	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—sarcoma	0.00412	0.00412	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—sarcoma	0.0041	0.0041	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—sarcoma	0.0041	0.0041	CcSEcCtD
Propericiazine—Confusional state—Thiotepa—sarcoma	0.00396	0.00396	CcSEcCtD
Propericiazine—Agitation—Vincristine—sarcoma	0.00392	0.00392	CcSEcCtD
Propericiazine—Vision blurred—Mitoxantrone—sarcoma	0.00391	0.00391	CcSEcCtD
Propericiazine—Infection—Thiotepa—sarcoma	0.0039	0.0039	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—sarcoma	0.0039	0.0039	CcSEcCtD
Propericiazine—Infection—Dactinomycin—sarcoma	0.00387	0.00387	CcSEcCtD
Propericiazine—Tachycardia—Thiotepa—sarcoma	0.00383	0.00383	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—sarcoma	0.00368	0.00368	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—sarcoma	0.00366	0.00366	CcSEcCtD
Propericiazine—Somnolence—Thiotepa—sarcoma	0.00349	0.00349	CcSEcCtD
Propericiazine—Oedema—Vincristine—sarcoma	0.00348	0.00348	CcSEcCtD
Propericiazine—Infection—Vincristine—sarcoma	0.00346	0.00346	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—sarcoma	0.00342	0.00342	CcSEcCtD
Propericiazine—Confusional state—Mitoxantrone—sarcoma	0.00342	0.00342	CcSEcCtD
Propericiazine—Oedema—Mitoxantrone—sarcoma	0.00339	0.00339	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—sarcoma	0.00339	0.00339	CcSEcCtD
Propericiazine—Infection—Mitoxantrone—sarcoma	0.00337	0.00337	CcSEcCtD
Propericiazine—Hyperhidrosis—Vincristine—sarcoma	0.00336	0.00336	CcSEcCtD
Propericiazine—Constipation—Thiotepa—sarcoma	0.00336	0.00336	CcSEcCtD
Propericiazine—Tachycardia—Mitoxantrone—sarcoma	0.00331	0.00331	CcSEcCtD
Propericiazine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00328	0.00328	CcSEcCtD
Propericiazine—Hypotension—Vincristine—sarcoma	0.00325	0.00325	CcSEcCtD
Propericiazine—Hypotension—Mitoxantrone—sarcoma	0.00317	0.00317	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—sarcoma	0.00317	0.00317	CcSEcCtD
Propericiazine—Insomnia—Vincristine—sarcoma	0.00315	0.00315	CcSEcCtD
Propericiazine—Body temperature increased—Thiotepa—sarcoma	0.0031	0.0031	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—sarcoma	0.00308	0.00308	CcSEcCtD
Propericiazine—Dyspnoea—Mitoxantrone—sarcoma	0.00302	0.00302	CcSEcCtD
Propericiazine—Somnolence—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Propericiazine—Constipation—Vincristine—sarcoma	0.00298	0.00298	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—sarcoma	0.00293	0.00293	CcSEcCtD
Propericiazine—Constipation—Mitoxantrone—sarcoma	0.0029	0.0029	CcSEcCtD
Propericiazine—Hypersensitivity—Thiotepa—sarcoma	0.00289	0.00289	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—sarcoma	0.00287	0.00287	CcSEcCtD
Propericiazine—Confusional state—Etoposide—sarcoma	0.00284	0.00284	CcSEcCtD
Propericiazine—Infection—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Propericiazine—Asthma—Epirubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—sarcoma	0.00275	0.00275	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Propericiazine—Body temperature increased—Vincristine—sarcoma	0.00275	0.00275	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—sarcoma	0.00273	0.00273	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—sarcoma	0.00271	0.00271	CcSEcCtD
Propericiazine—Diarrhoea—Thiotepa—sarcoma	0.00269	0.00269	CcSEcCtD
Propericiazine—Body temperature increased—Mitoxantrone—sarcoma	0.00268	0.00268	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—sarcoma	0.00267	0.00267	CcSEcCtD
Propericiazine—Hypotension—Etoposide—sarcoma	0.00263	0.00263	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Propericiazine—Hypersensitivity—Vincristine—sarcoma	0.00256	0.00256	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—sarcoma	0.00251	0.00251	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Propericiazine—Somnolence—Etoposide—sarcoma	0.00251	0.00251	CcSEcCtD
Propericiazine—Hypersensitivity—Mitoxantrone—sarcoma	0.0025	0.0025	CcSEcCtD
Propericiazine—Vomiting—Thiotepa—sarcoma	0.0025	0.0025	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—sarcoma	0.00248	0.00248	CcSEcCtD
Propericiazine—Rash—Thiotepa—sarcoma	0.00247	0.00247	CcSEcCtD
Propericiazine—Dermatitis—Thiotepa—sarcoma	0.00247	0.00247	CcSEcCtD
Propericiazine—Rash—Dactinomycin—sarcoma	0.00246	0.00246	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Propericiazine—Constipation—Etoposide—sarcoma	0.00241	0.00241	CcSEcCtD
Propericiazine—Diarrhoea—Vincristine—sarcoma	0.00238	0.00238	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Propericiazine—Nausea—Thiotepa—sarcoma	0.00233	0.00233	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Propericiazine—Diarrhoea—Mitoxantrone—sarcoma	0.00232	0.00232	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—sarcoma	0.00231	0.00231	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—sarcoma	0.00223	0.00223	CcSEcCtD
Propericiazine—Vomiting—Vincristine—sarcoma	0.00221	0.00221	CcSEcCtD
Propericiazine—Rash—Vincristine—sarcoma	0.00219	0.00219	CcSEcCtD
Propericiazine—Dermatitis—Vincristine—sarcoma	0.00219	0.00219	CcSEcCtD
Propericiazine—Vomiting—Mitoxantrone—sarcoma	0.00215	0.00215	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Propericiazine—Rash—Mitoxantrone—sarcoma	0.00214	0.00214	CcSEcCtD
Propericiazine—Dermatitis—Mitoxantrone—sarcoma	0.00213	0.00213	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Propericiazine—Nausea—Vincristine—sarcoma	0.00207	0.00207	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Propericiazine—Nausea—Mitoxantrone—sarcoma	0.00201	0.00201	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Propericiazine—Vomiting—Etoposide—sarcoma	0.00179	0.00179	CcSEcCtD
Propericiazine—Agitation—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Propericiazine—Rash—Etoposide—sarcoma	0.00178	0.00178	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—sarcoma	0.00178	0.00178	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Propericiazine—Nausea—Etoposide—sarcoma	0.00167	0.00167	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Propericiazine—Oedema—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Propericiazine—Infection—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Propericiazine—Infection—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Propericiazine—Constipation—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Propericiazine—Rash—Epirubicin—sarcoma	0.000996	0.000996	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—sarcoma	0.000995	0.000995	CcSEcCtD
Propericiazine—Nausea—Epirubicin—sarcoma	0.000939	0.000939	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—sarcoma	0.00093	0.00093	CcSEcCtD
Propericiazine—Rash—Doxorubicin—sarcoma	0.000922	0.000922	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—sarcoma	0.000921	0.000921	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—sarcoma	0.000868	0.000868	CcSEcCtD
